Aligos Therapeutics ALGS SEC Filings

NASDAQ ALGS
$5.23 +0.20 (+4.15%)
As of: Oct 21, 2026 · 10:39 AM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Aligos Therapeutics, Inc. (ALGS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001193125-26-391880Sep 15, 2026 4:03 PM
2S-8Prospectus0001193125-26-337937Aug 6, 2026 8:04 PM
310-QQuarterly & Annual Report0001193125-26-336851Aug 6, 2026 12:07 PM
48-KCurrent Report0001171843-26-005294Aug 6, 2026 12:00 PM
54Insider Transaction0001610717-26-000305Jun 29, 2026 8:38 PM
64Insider Transaction0001610717-26-000304Jun 29, 2026 8:37 PM
74Insider Transaction0001610717-26-000303Jun 29, 2026 8:37 PM
84Insider Transaction0001610717-26-000302Jun 29, 2026 8:36 PM
94Insider Transaction0001610717-26-000301Jun 29, 2026 8:36 PM
104Insider Transaction0001610717-26-000300Jun 29, 2026 8:35 PM
118-KCurrent Report0001193125-26-285426Jun 26, 2026 8:02 PM
12SCHEDULE 13DBeneficial Ownership Report0001193125-26-281134Jun 24, 2026 8:30 PM
13SCHEDULE 13GBeneficial Ownership Report0001193125-26-226938May 15, 2026 8:30 PM
14SCHEDULE 13GBeneficial Ownership Report0000919574-26-003231May 15, 2026 1:05 PM
1510-QQuarterly & Annual Report0001193125-26-212001May 7, 2026 8:18 PM
1610-QQuarterly & Annual Report0001193125-26-212001May 7, 2026 8:18 PM
1710-QQuarterly & Annual Report0001193125-26-212001May 7, 2026 8:18 PM
188-KCurrent Report0001171843-26-003156May 7, 2026 8:08 PM
198-KCurrent Report0001171843-26-003156May 7, 2026 8:08 PM
208-KCurrent Report0001171843-26-003156May 7, 2026 8:08 PM
21DEFA14AOthers0001193125-26-191940Apr 29, 2026 8:33 PM
22ARSOthers0001193125-26-191897Apr 29, 2026 8:29 PM
23DEF 14AOthers0001193125-26-191843Apr 29, 2026 8:25 PM
248-KCurrent Report0001193125-26-166987Apr 21, 2026 8:32 PM
258-KCurrent Report0001193125-26-154927Apr 14, 2026 8:17 PM
264Insider Transaction0001610717-26-000095Mar 11, 2026 8:19 PM
274Insider Transaction0001610717-26-000095Mar 11, 2026 8:19 PM
284Insider Transaction0001610717-26-000095Mar 11, 2026 8:19 PM
294Insider Transaction0001610717-26-000094Mar 11, 2026 8:14 PM
304Insider Transaction0001610717-26-000094Mar 11, 2026 8:14 PM
314Insider Transaction0001610717-26-000094Mar 11, 2026 8:14 PM
324Insider Transaction0001610717-26-000093Mar 11, 2026 8:13 PM
334Insider Transaction0001610717-26-000093Mar 11, 2026 8:13 PM
344Insider Transaction0001610717-26-000093Mar 11, 2026 8:13 PM
354Insider Transaction0001610717-26-000092Mar 11, 2026 8:13 PM
364Insider Transaction0001610717-26-000092Mar 11, 2026 8:13 PM
374Insider Transaction0001610717-26-000092Mar 11, 2026 8:13 PM
38S-8Prospectus0001193125-26-092647Mar 5, 2026 1:28 PM
3910-KQuarterly & Annual Report0001193125-26-092614Mar 5, 2026 1:08 PM
408-KCurrent Report0001171843-26-001340Mar 5, 2026 1:01 PM
413Insider Transaction0001610717-26-000055Feb 19, 2026 10:54 PM
42SCHEDULE 13GBeneficial Ownership Report0000902664-26-001065Feb 17, 2026 8:22 PM
43SCHEDULE 13GBeneficial Ownership Report0000902664-26-001065Feb 17, 2026 8:22 PM
44SCHEDULE 13GBeneficial Ownership Report0000902664-26-001065Feb 17, 2026 8:22 PM
45SCHEDULE 13GBeneficial Ownership Report0001214659-26-001502Feb 11, 2026 9:32 PM
468-KCurrent Report0001193125-26-037558Feb 4, 2026 9:05 PM
47SCHEDULE 13GBeneficial Ownership Report0000902664-25-005026Nov 14, 2025 9:15 PM
4810-QQuarterly & Annual Report0001193125-25-268203Nov 6, 2025 1:37 PM
498-KCurrent Report0001171843-25-007075Nov 6, 2025 1:30 PM
50SCHEDULE 13GBeneficial Ownership Report0000902664-25-003590Aug 14, 2025 3:54 PM
...

Aligos Therapeutics, Inc. SEC Filings API

Pull Aligos Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ALGS&formtype=10-K,10-Q&api_key=YOUR_API_KEY